Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X F Hu

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Zhonghua Fu Chan Ke Za Zhi|November 1, 1988
[The production and identification of OC859--a monoclonal antibody against tumor associated antigen in ovarian epithelial carcinoma]X F Hu
Zhonghua Fu Chan Ke Za Zhi|January 1, 1988
[Production of polyclonal antibody against ovarian epithelial carcinoma and its use in tumor localization]X F Hu
Zhonghua Yi Shi Za Zhi (Beijing, China : 1980)|January 17, 2019
[Types and characteristics of advertising images in Chinese medicine works during the Republic of China]H Geng, X F Hu
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|January 15, 2003
[A review of the study on the processing of Chinese herbal drugs in past two years]X F Hu, G J Yuan
Zhonghua Fu Chan Ke Za Zhi|March 1, 1985
[Immunologic function of ovarian cancer]X F Hu, L J Lian
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|July 6, 2018
[Research progress of xerostomia assessment tools]X F Hu, Y P Ding
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|August 1, 1983
[Evaluation on cellular immunity in patients with gynecological tumors by lymphoblast transformation test]W S Liu, X F Hu
Zhonghua Yi Xue Za Zhi|April 21, 2024
[Current status and prospects of genetic research on membranous nephropathy]X F Hu, J Y Xie
Zhonghua Nei Ke Za Zhi|July 5, 2016
[An update of rituximab treatment in idiopathic membranous nephropathy]X F Hu, J Xu, N Chen
Histology and Histopathology|May 16, 2007
Advances of MUC1 as a target for breast cancer immunotherapyE Yang, X F Hu, P X Xing
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Zhonghua Fu Chan Ke Za Zhi|November 1, 1988
[The production and identification of OC859--a monoclonal antibody against tumor associated antigen in ovarian epithelial carcinoma]X F Hu
Zhonghua Fu Chan Ke Za Zhi|January 1, 1988
[Production of polyclonal antibody against ovarian epithelial carcinoma and its use in tumor localization]X F Hu
Zhonghua Yi Shi Za Zhi (Beijing, China : 1980)|January 17, 2019
[Types and characteristics of advertising images in Chinese medicine works during the Republic of China]H Geng, X F Hu
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|January 15, 2003
[A review of the study on the processing of Chinese herbal drugs in past two years]X F Hu, G J Yuan
Zhonghua Fu Chan Ke Za Zhi|March 1, 1985
[Immunologic function of ovarian cancer]X F Hu, L J Lian
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|July 6, 2018
[Research progress of xerostomia assessment tools]X F Hu, Y P Ding
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|August 1, 1983
[Evaluation on cellular immunity in patients with gynecological tumors by lymphoblast transformation test]W S Liu, X F Hu
Zhonghua Yi Xue Za Zhi|April 21, 2024
[Current status and prospects of genetic research on membranous nephropathy]X F Hu, J Y Xie
Zhonghua Nei Ke Za Zhi|July 5, 2016
[An update of rituximab treatment in idiopathic membranous nephropathy]X F Hu, J Xu, N Chen
Histology and Histopathology|May 16, 2007
Advances of MUC1 as a target for breast cancer immunotherapyE Yang, X F Hu, P X Xing
Pageof 6